Brammer Biopharmaceuticals Overview

  • Founded
  • 2015

  • Status
  • Acquired/​Merged

  • Employees
  • 350

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

  • Investments
  • 1

Brammer Biopharmaceuticals General Information


Provider of best-in-class cell and gene therapy designed to improve patient health. The company's cell and gene therapy enabling pharmaceuticals and biotech clients to accelerate the delivery of novel medicines.

Contact Information

Ownership Status
Financing Status
Formerly PE-Backed
Primary Industry
Primary Office
  • PO Box 267
  • Lexington, MA 02420
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brammer Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Brammer Biopharmaceuticals‘s full profile, request access.

Request a free trial

Brammer Biopharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Mark Bamforth Co-Founder, President & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Brammer Biopharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Brammer Biopharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 (00000 01-Jan-2017 0000000000 Buildings and Property
To view Brammer Biopharmaceuticals’s complete acquisitions history, request access »